New data show Abbott’s FreeStyle® Libre 14 day system significantly reduces costs associated with diabetes management and complications

Cost model data published in U.S. Endocrinology show for commercially-insured people with diabetes on intensive insulin therapy, using FreeStyle Libre technology costs 60% less compared to traditional blood glucose monitoring This cost-savings includes costs associated with severe hypoglycemia, including hospitalizations, which were approximately 50% less for FreeStyle Libre 14 day system users versus testing with…

Details

Trump Administration Sets Demographic Requirements for Coronavirus Reports

WASHINGTON — The Trump administration on Thursday released new requirements for states to report coronavirus data based on race, ethnicity, age and sex of individuals tested for the virus, responding to demands from lawmakers for a clearer picture of the pandemic and its racial discrepancies. All laboratories — as well as nonlaboratory facilities offering on-site…

Details

Doctors Heavily Overprescribed Antibiotics Early in the Pandemic

The desperately ill patients who deluged the emergency room at Detroit Medical Center in March and April exhibited the telltale symptoms of the coronavirus: high fevers and infection-riddled lungs that left them gasping for air. With few treatment options, doctors turned to a familiar intervention: broad-spectrum antibiotics, the shot-in-the-dark medications often used against bacterial infections…

Details